Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.56/Share

Go back to Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.56/Share
(NASDAQ: ACRS) Delayed: 4.46 +0.05 (1.13%)
Previous Close $4.41    52 Week High $33.88 
Open $4.44    52 Week Low $14.12 
Day High $4.52    P/E N/A 
Day Low $4.36    EPS $0.00 
Volume 2,000,132